BCL2 and lymphoma: A lack of BCL2 protein expression in primary high-grade lymphomas, i.e., BCL2- negative defined as being present in <50% of cells, was associated with a very low venetoclax response (the mean response was 30.3% for BCL2+ and 6.3% for BCL2-negative, p = 0.0371, Figure 4B).